Skip to content

Stem cells for regeneration of bone tissue.

Bone tissue bioengineering using stem cells.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3pf767
Enrollment
Unknown
Registered
2019-01-11
Start date
2015-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non syndromic unilateral cleft lip and palate

Interventions

Group (1) Mesenchymal stem cells graft associated with biomaterials. Mesenchymal stem cells obtained from autogenous deciduous dental pulp is associated with hydroxyatite and collagen. The stem cells
Biological/vaccine

Sponsors

Hospital Municipal Infantil Menino Jesus
Collaborator
Hospital Sírio-Libanês
Lead Sponsor

Eligibility

Age
8 Years to No maximum

Inclusion criteria

Inclusion criteria: 20 patients with unilateral alveolar cleft defects, aged 8 to 12 years, were selected at the Cleft Lip and Palate Unit of the Hospital Municipal Infantil Menino Jesus. All patients underwent preoperative orthodontic expansion of maxillary segments.

Exclusion criteria

Exclusion criteria: Previous alveolar surgery, previous eruption of the canine or incomplete records.

Design outcomes

Primary

MeasureTime frame
EXPECTED OUTCOME 1 Alveolar bone filling* - Definition: percentage of filled area of fissure that was filled by the graft compared to the area in the preoperative alveolar fissure. - Method for evaluation: assessed by CT. - Time-point: pre-operative and 6 and 12 months post-intervention. - Type of variable: dichotomous * main primary outcome ;EXPECTED OUTCOME 2 Severe adverse events. - Definition: Severe adverse events are defined as those that bring threat to life, hospitalization, disability, fetal loss / abortion, malformation and death. - Method used to evaluate: percentage of patients with at least one severe adverse event according to observation of the surgeon, patients, family members or caregivers. - Time-point: 7 and 15 days post-intervention. - Type of variable: dichotomous

Secondary

MeasureTime frame
EXPECTED OUTCOME 3 Non serious adverse events - Definition: Non serious adverse events - Method used to evaluate: percentage of patients with at least one non serious adverse event according to observation of the surgeon, patients, family members or caregivers. - Time-point: 7 and 15 days post-intervention. - Type of variable: dichotomous ;EXPECTED OUTCOME 4 Canine position and root formation - Definition: percentage of patients with root formation of the canine tooth. Root formation is considered present when at least 2/3 of the root is formed. - Method used to evaluate: periapical radiography - Time-point: pre-intervention and 12 months after the intervention. - Type of variable: dichotomous;EXPECTED OUTCOME 5 Consumption of pain medications in the postoperative period - Definition: consumption of analgesic drugs (mg / kg body weight). - Method used to evaluate: data collected from the patient's register. - Time-point: intraoperative and postoperative (up to hospital discharge) - Type of variable: continuous (mean)

Countries

Brazil

Contacts

Public ContactDaniela Bueno

Hospital Sírio-Libanês

dbuenousp@gmail.com+55 11 33944195

Outcome results

None listed

Source: REBEC (via WHO ICTRP)